Recurrent outbreaks of the Ebola virus disease (EVD) pose substantial threats to Africa's health systems. Despite advancements such as vaccines and therapeutics, successful outbreak containment ...

Anuncia Medical, Inc. ("Anuncia"), a pioneering company in CSF management and neurocritical care, has received Breakthrough ...

Placing an external ventricular drain (EVD) at bedside using augmented reality (AR) guidance is more precise than freehand ...

EVDs are placed in more than 100,000 cases annually in the U.S. to relieve elevated intracranial pressure. The ReFlow® EVD is the first device of its kind to provide a noninvasive, manual ...

SCOTTSDALE, Ariz., March 20, 2025 /PRNewswire/ -- Anuncia Medical, Inc. ("Anuncia"), a pioneering company in CSF management and neurocritical care, has received Breakthrough Device Designation ...